• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Axonics Modulation Technologies, Inc. Axonics; Stimulator, Electrical, Implantable, For Incontinence

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Axonics Modulation Technologies, Inc. Axonics; Stimulator, Electrical, Implantable, For Incontinence Back to Search Results
Model Number 1101
Medical Device Problem Code Migration (4003)
Health Effect - Clinical Code Implant Pain (4561)
Date of Event 06/29/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient with the neurostimulator is experiencing pain at the pocket site.The device has been off for a while.The patient went to the emergency room and got a ct scan and the device shows migration.The patient underwent an explant on (b)(6) 2026.
 
Additional Manufacturer Narrative
Block d2b: additional pro code: qon.Block d10: model number/catalog number: 1201, serial number: (b)(6), batch/lot number: al1h721642, model/catalog description: 1201, unique identifier (udi) #: (b)(4).Block g4: additional premarket / 510 (k): p190006.The device was not returned for analysis; therefore, a technical analysis could not be performed.Good faith effort attempts were made to try and retrieve the device; however, device was discarded.It was confirmed the device met manufacturing specification prior to distribution and there were no manufacturing deviations which could have contributed to the reported event.Review of the instructions for use (ifu) confirmed there was relevant content and sufficient guidance with respect to the circumstances described within this complaint.No updates are required to the ifu as a result of this event.A risk review was completed and confirmed that the event of implant pain and migration was defined in the product risk documentation.This event type has been accounted for during analysis to support acceptable risk benefit for the product.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of cause not established.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Axonics
Common Device Name
Stimulator, Electrical, Implantable, For Incontinence
Manufacturer (Section D)
Axonics Modulation Technologies, Inc.
15515 sand canyon ave
irvine CA 92618
Manufacturer (Section G)
Axonics Inc
15515 sand canyon ave
irvine CA 92618
Manufacturer Contact
farshad fahimi
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key50072798
Report Number2124215-2026-40636
Device Sequence Number10361194
Product Code EZW
UDI-Device Identifier10810005340066
UDI-Public(01)10810005340066(11)210817(17)240817
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
P180046
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2026
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 07/29/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/17/2024
Device Model Number1101
Device Catalogue Number1101
Device Lot NumberAX1H174819
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/02/2026
Initial Report FDA Received Date07/29/2026
Date Device Manufactured08/17/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age38 YR
Patient SexFemale
-
-